Sort by
Refine Your Search
-
Category
-
Employer
-
Field
-
. PhD Position on Nanozyme-based coating for antimicrobial implants Your tasks Design and synthesize nanozymes: Develop nanozymes, and optimize their physicochemical and catalytic properties. Develop
-
systems. To get an overview of our lab's recent projects, take a look at our publications: https://drescherlab.org/publications.html We are looking for a highly motivated and talented PhD student to join
-
, trustworthiness, and human-AI interaction, with a focus on high-stakes settings. Publishing at top venues in AI and responsible AI research (NeurIPS, ICML, ICLR, ACL, FAccT, EAAMO, AIES, CHI, etc.). Designing
-
(R1) Positions PhD Positions Application Deadline 2 Oct 2026 - 17:00 (Europe/Zurich) Country Switzerland Type of Contract Temporary Job Status Full-time Offer Starting Date 1 Feb 2027 Is the job funded
-
the world, we work together to develop solutions for the global challenges of today and tomorrow. Where to apply Website https://academicpositions.com/ad/eth-zurich/2026/phd-position-in-nccr-genesis-o
-
connections all over the world, we work together to develop solutions for the global challenges of today and tomorrow. Where to apply Website https://academicpositions.com/ad/eth-zurich/2026/phd-position-in
-
the world, we work together to develop solutions for the global challenges of today and tomorrow. Where to apply Website https://academicpositions.com/ad/eth-zurich/2026/phd-position-in-cryogenic-carb
-
forward to receiving your application! Where to apply Website https://academicpositions.com/ad/university-of-basel/2026/phd-in-media-psycholo… Requirements Research FieldCommunication sciencesYears
-
connections all over the world, we work together to develop solutions for the global challenges of today and tomorrow. Where to apply Website https://academicpositions.com/ad/eth-zurich/2026/phd-on-quantum
-
of dynamic polymer networks; (ii) (bio)material processing; (iii) organ perfusion and regeneration; (iv) tools to study mechanobiology and cell–matrix interactions; and (v) engineered drug delivery